Literature DB >> 23303131

Humoral hypercalcemia associated with gastric carcinoma secreting parathyroid hormone: a case report and review of the literature.

Koji Nakajima1, Masataka Tamai, Shinji Okaniwa, Yoshiyuki Nakamura, Mutsuhiro Kobayashi, Tomohiro Niwa, Naoto Horigome, Nobuo Ito, Satoru Suzuki, Shinichi Nishio, Mitsuhisa Komatsu.   

Abstract

Hypercalcemia with concomitant elevation of serum parathyroid hormone (PTH) and PTH-related protein (PTHrP) levels was found in a patient with advanced gastric carcinoma and multiple liver metastases. The most common features are hypercalcemia associated with hypersecretion of PTHrP and physiological suppression of PTH secretion in the syndrome of humoral hypercalcemia of malignancy (HHM). Although we initially made a diagnosis of primary hyperparathyroidism concomitant with HHM due to gastric cancer, diagnostic imaging studies, such as echography, CT, sestamibi scintigraphy, and autopsy findings, did not reveal evidence of any parathyroid tumors or ectopic parathyroid glands in the mediastinum. Both primary and metastatic tumor cells showed positive staining with PTH-specific antibody as well as PTHrP-specific antibody on immunohistochemical examination. PTH concentration in the cytosolic fraction of the metastatic tumor was elevated compared to that from a control patient with no calcium metabolic disorders in vitro. These findings indicated that PTH secreted ectopically by gastric cancer cells, not by parathyroid glands, caused hypercalcemia in this patient. To our knowledge, this is the first case report of PTH-secreting gastric carcinoma cells. We report the case and a review of the previous reported PTH-secreting non-parathyroid tumors along with the mechanisms of secretion.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23303131     DOI: 10.1507/endocrj.ej12-0406

Source DB:  PubMed          Journal:  Endocr J        ISSN: 0918-8959            Impact factor:   2.349


  16 in total

Review 1.  Immunohistochemistry in Diagnostic Parathyroid Pathology.

Authors:  Lori A Erickson; Ozgur Mete
Journal:  Endocr Pathol       Date:  2018-06       Impact factor: 3.943

2.  Hypercalcemia as Initial Presentation of Metastatic Adenocarcinoma of Gastric Origin: A Case Report and Review of the Literature.

Authors:  Mehandar Kumar; Abhishek Kumar; Vinod Kumar; Supreet Kaur; Michael Maroules
Journal:  J Gastric Cancer       Date:  2016-09-30       Impact factor: 3.720

3.  Humoral hypercalcemia due to gastric carcinoma secreting parathyroid hormone-related protein during chemotherapy: a case report.

Authors:  Chikara Iino; Tadashi Shimoyama; Yui Akemoto; Takasato Igarashi; Tomoyuki Aihara; Kentaro Ishii; Juichi Sakamoto; Hiroshi Tono; Shinsaku Fukuda
Journal:  Clin J Gastroenterol       Date:  2016-03-14

4.  In serum, higher parathyroid hormone but not lower vitamin D is associated with oral squamous cell carcinoma.

Authors:  H Zhang; H Lu; C Shrestha; Y Feng; Y Li; J Peng; Y Li; Z Xie
Journal:  Curr Oncol       Date:  2015-08       Impact factor: 3.677

5.  The EANM practice guidelines for parathyroid imaging.

Authors:  Petra Petranović Ovčariček; Luca Giovanella; Ignasi Carrió Gasset; Elif Hindié; Martin W Huellner; Markus Luster; Arnoldo Piccardo; Theresia Weber; Jean-Noël Talbot; Frederik Anton Verburg
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-04-10       Impact factor: 9.236

6.  An unusual case of malignancy-related hypercalcemia.

Authors:  Mary-Anne Doyle; Janine C Malcolm
Journal:  Int J Gen Med       Date:  2013-12-06

7.  Parathyroid hormone-related protein serves as a prognostic indicator in oral squamous cell carcinoma.

Authors:  Zhongjing Lv; Xiangbing Wu; Wei Cao; ZongZe Shen; Lizhen Wang; FuRong Xie; JianJun Zhang; Tong Ji; Ming Yan; WanTao Chen
Journal:  J Exp Clin Cancer Res       Date:  2014-12-18

Review 8.  Hypercalcemia of malignancy and new treatment options.

Authors:  Hillel Sternlicht; Ilya G Glezerman
Journal:  Ther Clin Risk Manag       Date:  2015-12-04       Impact factor: 2.423

9.  Hypercalcemia of Malignancy Attributed to Cosecretion of PTH and PTHRP in Lung Adenocarcinoma.

Authors:  Jeffrey M Kroopnick; Ubaldo Martinez-Outschoorn; Madalina Tuluc; Caroline S Kim
Journal:  AACE Clin Case Rep       Date:  2021-01-19

10.  Pharmacogenetic analysis of cinacalcet response in secondary hyperparathyroidism patients.

Authors:  Sohyun Jeong; In-Wha Kim; Kook-Hwan Oh; Nayoung Han; Kwon Wook Joo; Hyo Jin Kim; Jung Mi Oh
Journal:  Drug Des Devel Ther       Date:  2016-07-08       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.